HCL Axon signs global IT Svcs deal with GlaxoSmithKline

ALSO READ See latest News about HCL Tech See previous management interviews See what other Experts & Brokerages are saying about HCL Tech HCL Tech BSE | NSE 09/02/12 Are Mutual Funds betting on HCL Tech?

HCL Axon, a division of HCL Technologies and the world's largest services provider dedicated to SAP® solutions, has announced that it has signed a five year Global Strategic Information Technology Master Services Agreement with GlaxoSmithKline (GSK), one of the world's largest pharmaceutical companies. This agreement describes how HCL Axon and HCL Technologies will provide systems integration, SAP implementation and IT consulting services to GSK globally.

The first activity under this agreement is to be GSK's systems integration partner for a large SAP-enabled business transformation programme the scope of which is in development. 

The GSK agreement is one more major global SAP transformation win for HCL Axon since HCL Technologies' acquisition of Axon in December 2008, a success achieved against stiff competition.

"This is an important win for us," said Steve Cardell, President, HCL Axon. "It keeps our strategy of becoming the largest global SAP-based business transformation provider firmly on track and confirms the rationale behind the merger with HCL."

David Mitchell, SVP, IT Research at analyst firm Ovum, commented "SAP continues to be a strategic application choice for many companies seeking to transform their business through an enterprise technology and services platform. Ensuring that such transformation programmes deliver true value needs a technology partner who understands the technology in-depth but who also truly understands business. HCL, amplified by their Axon acquisition, has a good blend of technology and business expertise to support GSK through the years ahead."

This win further accelerates HCL's rapid growth in the life science industry which is one of its fastest growing industry verticals.